Kintara pharmaceuticals
WebKINTARA THERAPEUTICS, INC. (KTRA) Geschatte financiële gegevens (e) Meer Financiële cijfers Bedrijfsprofiel Kintara Therapeutics, Inc. is een biofarmaceutisch bedrijf in een klinische fase dat zich richt op de ontwikkeling en commercialisering van nieuwe kankertherapieën. Web13 mrt. 2024 · Kintara Therapeutics, Inc. is a clinical-stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies.
Kintara pharmaceuticals
Did you know?
Web2 jan. 2024 · Kintara Pharmaceuticals is headquartered in San Diego, California, United States. The operating loss of the company was US$22.7 million in FY2024, compared to an operating loss of US$38.2 million in FY2024. The net loss of the company was US$22.7 million in FY2024, compared to a net loss of US$38.3 million in FY2024. Web2 jan. 2024 · Kintara provides warrants services, pre-clinical testing, and clinical trials, among others. It also conducts research and development on cancer indications. It has operations in the US and Canada. Kintara Pharmaceuticals is headquartered in San Diego, California, United States. Quick View Dianhydrogalactitol LOA Data Subscribe to …
WebKintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline … Web8 jan. 2024 · Day One Biopharmaceuticals is a clinical-stage company dedicated to developing and commercializing innovative targeted therapies for patients of all ages.
Web13 mrt. 2024 · KINTARA THERAPEUTICS, INC. : News, information and stories for KINTARA THERAPEUTICS, INC. Nasdaq: KTRA Nasdaq WebLocations Primary 12707 High Bluff Dr Suite 200 San Diego, California 92130, US Get directions 3475 Edison Way Suite R Menlo Park, California 94025, US Get directions See all employees Updates...
Web13 mrt. 2024 · KINTARA THERAPEUTICS, INC. company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: KTRA Nasdaq. ... VERTEX PHARMACEUTICALS INCORPORATED : Interim 2024 Earnings Release (Projected) 08/03/23 : REGENERON PHARMACEUTICALS, INC.
Web13 mrt. 2024 · Company. Kintara Therapeutics, Inc. is a clinical-stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. … lds old testament triviaWebKintara is a diversified biopharmaceutical company with multiple oncology product candidates in development, including VAL-083 for the treatment of drug-resistant solid … lds old testament coloring booksWebWe did a reverse takeover on January 25, 2013 and became DelMar Pharmaceuticals, Inc. On August 2024 we changed our name to Kintara Therapeutics, Inc. Where is Kintara Therapeutics, Inc. located? Kintara Therapeutics, Inc. 12707 High Bluff Drive Suite 200 San Diego, CA 92130. When is Kintara Therapeutics, Inc.'s fiscal year end? June 30 th lds old testament manual come follow meWeb14 apr. 2024 · Kintara Therapeutics Announces Data Presentation at the 2024 American Association for Cancer Research Annual Meeting. SAN DIEGO, April 14, 2024 … lds one percent betterWeb14 apr. 2024 · SAN DIEGO, April 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused … lds ohioWebKintara Therapeutics, Inc. EXEL: Raising target price to $16.00 EXELIXIS INC has an Investment Rating of SELL; a target price of $16.000000; an Industry Subrating of … lds o my father lyricsWebKintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2024. lds oliver cowdery